Stravitz Visionary Award supports early- to mid-career investigators pursuing innovative basic, translational, or clinical liver research to transform patient care and advance hepatology.
Funder: AASLD Foundation
Due Dates (Anticipated): January 2027 (Full application) | October 2027 (Letter of Intent)
Funding Amounts: $500,000 over three years
Summary: Supports innovative basic, translational, or clinical liver research with the potential to transform patient care.
Key Information: Applicants must be independent early- to mid-career faculty within 10 years of training and commit at least 30% effort.
The AASLD Foundation’s Stravitz Visionary Award supports highly innovative research that could transform care for patients with liver disease. This project-based award enables early- to mid-career investigators to pursue basic, translational, or clinical studies with broad and sustained impact in hepatology. It is not a mentored award: applicants must demonstrate their ability to conduct the proposed work independently.
Priority goes to innovative or transformative projects with human applications and to multidisciplinary research. Multiple-principal-investigator and multi-institution studies are considered. Selection examines the research’s significance and innovation, the rigor and feasibility of its approach, and the investigators’ expertise and institutional resources. The 2027 award is supported by the R. Todd Stravitz AASLD Foundation Research Fund.